117 related articles for article (PubMed ID: 29683852)
1. Reversing interferon-alpha neurotoxicity in a HIV-associated neurocognitive disorder mouse model.
Koneru R; Bimonte-Nelson H; Ciavatta V; Haile W; Elmore K; Ward J; Maroun L; Tyor WR
AIDS; 2018 Jul; 32(11):1403-1411. PubMed ID: 29683852
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha causes neuronal dysfunction in encephalitis.
Sas AR; Bimonte-Nelson H; Smothers CT; Woodward J; Tyor WR
J Neurosci; 2009 Mar; 29(12):3948-55. PubMed ID: 19321791
[TBL] [Abstract][Full Text] [Related]
3. Interferon-α induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor.
Kessing CF; Tyor WR
J Interferon Cytokine Res; 2015 Apr; 35(4):317-24. PubMed ID: 25517826
[TBL] [Abstract][Full Text] [Related]
4. Interferon-α (IFNα) neurotoxicity.
Fritz-French C; Tyor W
Cytokine Growth Factor Rev; 2012; 23(1-2):7-14. PubMed ID: 22342642
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
Anderson AM; Lennox JL; Mulligan MM; Loring DW; Zetterberg H; Blennow K; Kessing C; Koneru R; Easley K; Tyor WR
J Neurovirol; 2017 Feb; 23(1):106-112. PubMed ID: 27400930
[TBL] [Abstract][Full Text] [Related]
6. Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro.
Gavegnano C; Haile WB; Hurwitz S; Tao S; Jiang Y; Schinazi RF; Tyor WR
J Neuroinflammation; 2019 Sep; 16(1):182. PubMed ID: 31561750
[TBL] [Abstract][Full Text] [Related]
7. A mouse model of HIV-associated neurocognitive disorders: a brain-behavior approach to discover disease mechanisms and novel treatments.
Tyor WR; Bimonte-Nelson H
J Neurovirol; 2018 Apr; 24(2):180-184. PubMed ID: 28895064
[TBL] [Abstract][Full Text] [Related]
8. Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model.
Koneru R; Olive MF; Tyor WR
J Neurovirol; 2014 Feb; 20(1):9-17. PubMed ID: 24415129
[TBL] [Abstract][Full Text] [Related]
9. The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse model.
Fritz-French C; Shawahna R; Ward JE; Maroun LE; Tyor WR
J Interferon Cytokine Res; 2014 Jul; 34(7):510-7. PubMed ID: 24564363
[TBL] [Abstract][Full Text] [Related]
10. Induction of Interleukin-1β by Human Immunodeficiency Virus-1 Viral Proteins Leads to Increased Levels of Neuronal Ferritin Heavy Chain, Synaptic Injury, and Deficits in Flexible Attention.
Festa L; Gutoskey CJ; Graziano A; Waterhouse BD; Meucci O
J Neurosci; 2015 Jul; 35(29):10550-61. PubMed ID: 26203149
[TBL] [Abstract][Full Text] [Related]
11. Cognitive dysfunction in HIV encephalitic SCID mice correlates with levels of Interferon-alpha in the brain.
Sas AR; Bimonte-Nelson HA; Tyor WR
AIDS; 2007 Oct; 21(16):2151-9. PubMed ID: 18090041
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system.
Akay C; Cooper M; Odeleye A; Jensen BK; White MG; Vassoler F; Gannon PJ; Mankowski J; Dorsey JL; Buch AM; Cross SA; Cook DR; Peña MM; Andersen ES; Christofidou-Solomidou M; Lindl KA; Zink MC; Clements J; Pierce RC; Kolson DL; Jordan-Sciutto KL
J Neurovirol; 2014 Feb; 20(1):39-53. PubMed ID: 24420448
[TBL] [Abstract][Full Text] [Related]
13. Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered.
Gelman BB
Curr HIV/AIDS Rep; 2015 Jun; 12(2):272-9. PubMed ID: 25860316
[TBL] [Abstract][Full Text] [Related]
14. BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism.
Stern AL; Ghura S; Gannon PJ; Akay-Espinoza C; Phan JM; Yee AC; Vassar R; Gelman BB; Kolson DL; Jordan-Sciutto KL
J Neurosci; 2018 May; 38(18):4288-4300. PubMed ID: 29632166
[TBL] [Abstract][Full Text] [Related]
15. Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.
Yuan NY; Kaul M
J Neuroimmune Pharmacol; 2021 Mar; 16(1):90-112. PubMed ID: 31385157
[TBL] [Abstract][Full Text] [Related]
16. A pivotal role for Interferon-α receptor-1 in neuronal injury induced by HIV-1.
Singh H; Ojeda-Juárez D; Maung R; Shah R; Roberts AJ; Kaul M
J Neuroinflammation; 2020 Jul; 17(1):226. PubMed ID: 32727588
[TBL] [Abstract][Full Text] [Related]
17. PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy.
Vera JH; Ridha B; Gilleece Y; Amlani A; Thorburn P; Dizdarevic S
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):895-902. PubMed ID: 28058461
[TBL] [Abstract][Full Text] [Related]
18. Interrogating the impact of combination antiretroviral therapies on HIV-associated neurocognitive disorders.
Sharma I
HIV Med; 2021 Oct; 22(9):783-790. PubMed ID: 34291558
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution.
Villeneuve LM; Purnell PR; Stauch KL; Callen SE; Buch SJ; Fox HS
J Neurovirol; 2016 Oct; 22(5):564-574. PubMed ID: 26843384
[TBL] [Abstract][Full Text] [Related]
20. Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND).
Kolson DL
Curr HIV/AIDS Rep; 2022 Oct; 19(5):344-357. PubMed ID: 35867211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
